A Case of Acneiform Eruption and Paronychia Occurring after Use of Erlotinib (Tarceva(R)) / 대한피부과학회지
Korean Journal of Dermatology
;
: 1180-1182, 2007.
Article
in Korean
| WPRIM
| ID: wpr-116305
ABSTRACT
Erlotinib (Tarceva(R)) is a new anti-cancer agent which acts by inhibiting epidermal growth factor receptor (EGFR) signal transduction. It is currently used in the treatment of advanced stage non-small cell lung cancer and pancreatic cancer. We report a case of acneiform eruption and paronychia induced by erlotinib in a 69-year-old man. The patient visited our clinic with multiple erythematous papules and pustules on the face, periungual erythema and pus discharge, xerosis, fissures on the sole. He had taken erlotinib for the treatment of recurred lung cancer for 4 weeks. The skin lesions were partially improved with oral pyridoxine, corticosteroid and topical antibiotics.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pancreatic Neoplasms
/
Paronychia
/
Pyridoxine
/
Skin
/
Suppuration
/
Signal Transduction
/
Acneiform Eruptions
/
Carcinoma, Non-Small-Cell Lung
/
Erythema
/
ErbB Receptors
Limits:
Aged
/
Humans
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS